Financhill
Buy
58

CORBF Quote, Financials, Valuation and Earnings

Last price:
$1.09
Seasonality move :
-2.13%
Day range:
$1.09 - $1.09
52-week range:
$0.25 - $2.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.68x
P/B ratio:
0.19x
Volume:
--
Avg. volume:
4.9K
1-year change:
-12.8%
Market cap:
$146M
Revenue:
--
EPS (TTM):
--

Earnings Data

Next earnings date for CORBF
May 15
2025
Most recent earnings per share
$0.14
Beat by $0.14
(Mar 31/2022)
Consensus Estimate
--
(Mar 31/2022)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORBF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2022 Q1 -- $46.8M $0.14 -- --
12/31/2021 Q4 -- $49.6M $0.17 -- --
09/30/2021 Q3 -- $48.4M $0.16 -- --
06/30/2021 Q2 -- $48.8M $0.17 -- --
03/31/2021 Q1 -- $46.6M $0.16 -- --
12/31/2020 Q4 -- $43.9M $0.14 -- --
09/30/2020 Q3 -- $41.2M $0.16 -- --
06/30/2020 Q2 -- $39.6M $0.15 -- --
03/31/2020 Q1 -- $43M $0.11 -- --
12/31/2019 Q4 -- $47.5M $0.17 -- --
09/30/2019 Q3 -- $44.7M $0.14 -- --
06/30/2019 Q2 -- $40.1M $0.13 -- --
03/31/2019 Q1 -- $37.3M $0.11 -- --
12/31/2018 Q4 -- $36.8M $0.07 -- --
09/30/2018 Q3 -- $36.3M $0.08 -- --
06/30/2018 Q2 -- $36.7M $0.10 -- --
03/31/2018 Q1 $39.4M $36.6M $0.04 $0.13 -$0.09
12/31/2017 Q4 $38.3M $37M $0.09 $0.13 -$0.04
09/30/2017 Q3 -- $35.2M $0.09 -- --
06/30/2017 Q2 -- $32.7M $0.09 -- --
03/31/2017 Q1 -- $29.3M $0.07 -- --
12/31/2016 Q4 -- $29.1M $0.10 -- --
09/30/2016 Q3 -- $27.6M $0.03 -- --
06/30/2016 Q2 $26.2M $26.5M $0.03 $0.03 $0.00
03/31/2016 Q1 -- $24M $0.03 -- --
12/31/2015 Q4 -- $26.5M $0.10 -- --
09/30/2015 Q3 -- $27.2M $0.04 -- --
06/30/2015 Q2 -- $26.6M $0.03 -- --

Global Cord Blood Earnings Questions

  • How Much did Global Cord Blood Generate in Revenue Last Quarter?

    Global Cord Blood reported $46.8M worth of top line sales in its most recent quarter.

  • Did Global Cord Blood Beat Earnings Last Quarter?

    Global Cord Blood announced earnings per share of $0.14 which represents a beat of analyst forecast a -- per share.

  • Is Global Cord Blood Profitable?

    Global Cord Blood reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Global Cord Blood EPS Next Year?

    Global Cord Blood's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.

  • When is Global Cord Blood's Earnings Date?

    Global Cord Blood's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
92
TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock